Holanamine is a compound used to combat Leishmania donovani and has been identified as a non-competitive inhibitor of LdToP1B. Docking studies reveal that Holanamine exerts its antileishmanial effects through hydrogen bonds and hydrophobic interactions with the N-terminal and hinge regions of the LTop1B large subunit.